GraniteShares 2x Long COIN Daily ETF vs TransMedics Group Inc — how do they compare? GraniteShares 2x Long COIN Daily ETF trades at $4.12, while TransMedics Group Inc trades at $87 (market cap $3.02B). The key difference: TransMedics Group Inc is trading nearer its 52-week high, GraniteShares 2x Long COIN Daily ETF nearer its low. Which is the better fit depends on your goals.
| CONL | TMDX | |
|---|---|---|
Sector | Leveraged / Inverse | Technology |
52-Week High | $48.70 | $150.42 |
52-Week Low | $3.93 | $61.99 |
Market Cap | — | $3.02B |
Enterprise Value | — | $3.41B |
Signals from Pluang's Aura AI — not financial advice
CONL, the GraniteShares 2x Long COIN Daily ETF, trades at $4.11, up 0.49% on the day but reflecting a bearish technical signal with moving averages indicating strong selling pressure. The ETF has experienced significant volatility and value erosion, with news highlighting a 67% year-to-date loss as of June 2026 due to the daily-reset leverage structure amplifying Coinbase's price swings. Key financial ratios are not applicable as this is a leveraged ETF tracking another security.
Outlook remains highly speculative and risky due to the ETF's daily leverage, which can lead to rapid losses in volatile markets. Investment opportunity is limited to short-term traders betting on Coinbase rallies, but risks include volatility decay, tracking error, and dependence on Coinbase performance. Long-term holding is discouraged by the structure's inherent erosion.
TransMedics Group (TMDX) trades at $87.02, down 1.57% today, amid mixed signals. The stock shows a bullish technical trend with moving averages supporting upside, but oscillators like RSI indicate overbought conditions near 78. Fundamentally, the company reported record Q2 2026 revenue but missed earnings estimates, with net income margin declining to 22.69% from 31.42% in 2025. Recent news highlights an ongoing investigation into fiduciary duties by Rosen Law Firm, adding uncertainty.
The outlook remains cautiously optimistic with a consensus price target of $99.57, implying 14% upside, supported by strong analyst buy ratings (69%). However, risks include earnings volatility, margin pressure from rising costs, and legal scrutiny. Investors should weigh robust revenue growth against execution risks and elevated valuation multiples like a P/E of 23.15.
Trailing returns across standard periods
CONL is a leveraged ETF that seeks to provide two times (2x) the daily performance of Coinbase Global (COIN) stock. It is designed for investors seeking magnified short-term exposure to the price movements of Coinbase.
Read more on CONL →TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →